The much-anticipated results of a trial of more than 800 participants in Japan revealed that, when coupled with standard chemotherapy, the drug panitumumab lowered the risk of death by 18% ...

Background Panitumumab is a fully human antibody against the epidermal growth factor receptor that is indicated for the treatment of metastatic colorectal cancer (mCRC) after disease progression ...

The FDA is looking at four events for the remainder of October, one of which is an advisory committee meeting for a dual SGLT ...

This has recently led the FDA to approve revisions of the labels for cetuximab and panitumumab noting that the use of these mAbs is not recommended for such patients.

Talk with your doctor if you have questions about the side effects of Lumakras or panitumumab, either when used together or separately. Unlike chemotherapy, Lumakras is a targeted therapy that ...

This study is pending funding from the NIH. Comparison of 89Zr panitumumab and 18F-Fluorodeoxyglucose to Identify Head and Neck Cancer In collaboration with Dr. Suzy Lapi (Radiology), this study is a ...

While personalized medicine brings benefits for the treatment of cancer, there are still key ethical issues at stake in developing personalized medicine in oncology. We propose an ethical analysis ...

Read more about A trial of pembrolizumab before surgery for bowel cancer (NEOPRISM-CRC) A trial to find out if more people with bowel cancer could have cetuximab and panitumumab (ARIEL) This trial is ...

Some that may be used are Avastin (bevacizumab), Erbitux (cetuximab), Vectibix (panitumumab), Zaltrap (ziv-aflibercept), Cyramza (ramucirumab), Stivarga (regorafenib), and Fruzaqla (fruquintinib).

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...